What is it about?
This study describes a high throughput screen to identify a novel small molecule called Kenpaullone that is able to induce sprouting of lymphatic vessels. Kenpaullone was shown to signal through MAP4K4 and induce up-regulation of vascular endothelial growth factor D (VEGFD) and was effective in promoting lymphatic vessel growth in the injured adult mouse heart.
Featured Image
Photo by Louis Reed on Unsplash
Why is it important?
The findings are important because increasing lymphatic vessel growth in the injured heart has been shown to improve outcome through tissue fluid clearance and trafficking of immune cells. To date this has only been attributed to VEGFC, which is suboptimal as a potential drug, therefore discovery of Kenpaullone as a small molecule alternative has significant therapeutic implications.
Perspectives
This study is the culmination of many years developing and optimising the high throughput sprouting assay, the imaging pipelines and functional validation studies. It was led by the first author Christophe Ravaud who worked tirelessly on the project and benefitted from a terrific collaboration with our close medicinal chemistry colleague Professor Angie Russell In Oxford. I’m delighted to see this study published in PNAS.
Paul Riley
University of Oxford
This project was particularly rewarding because it brought together several aspects of research that I enjoy: developing and adapting a new assay, performing phenotypic screening, following up unexpected hits, and trying to understand the biology behind them. I found it particularly exciting to see how a relatively simple 3D spheroid assay could lead to findings that could then be investigated at the molecular and whole-organism levels. One of the highlights of the project was the opportunity to work closely with our medicinal chemistry colleagues, which was a new area of research for me. I particularly enjoyed working with Caroline Cuoco, a very talented PhD student, and seeing how our complementary expertise could be combined to explore different aspects of the screening hits and their mechanisms. I hope that the screening approach developed here will be useful beyond this study and contribute to identifying new ways of manipulating the lymphatic vasculature, particularly in the context of cardiac repair after myocardial infarction.
Christophe Ravaud
University of Oxford
Read the Original
This page is a summary of: Phenotypic screening identifies kenpaullone as a prolymphangiogenic compound to improve heart repair following myocardial infarction, Proceedings of the National Academy of Sciences, October 2026, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2619427123.
You can read the full text:
Resources
Contributors
The following have contributed to this page







